Understanding Mpox: What You Need to Know
As the World Health Organization (WHO) declares a global public health emergency due to the increasing spread of mpox, many questions arise about this concerning virus. Mpox, formerly known as monkeypox, has raised alarms globally, with fears of it crossing international borders. But what exactly is mpox, how does it spread, and can smallpox vaccines provide protection? Let’s dive into some of the most common questions and answers about mpox.
The Spread of Mpox and its Symptoms
The mpox virus can be classified into two types: clade I and clade II. Both types spread through contact with infected animals or people, contaminated materials, and bodily fluids. The virus transfers through direct contact with skin rashes, respiratory droplets, and even from an infected pregnant person to a fetus. Mpox can also spread from animals to humans through bites, scratches, and consumption of infected wild game or contact with contaminated animal products.
According to health experts, mpox can survive on surfaces for weeks, emphasizing the importance of proper cleaning and disinfection. The symptoms of mpox typically manifest 3 to 17 days after exposure, including fever, skin rash, swollen lymph nodes, and muscle aches. The rash progresses through different stages, including scabs, before healing.
Mpox Vaccines and Protection
While there is no specific treatment for mpox, antiviral drugs used for smallpox, like tecovirimat and brincidofovir, may be prescribed to manage the symptoms. Smallpox vaccines have shown effectiveness in preventing mpox, as both diseases are caused by related viruses. Vaccines like JYNNEOS and ACAM2000 can be used to protect against mpox.
Studies have indicated that smallpox vaccinations can offer significant protection against mpox. Research has shown that individuals who received smallpox vaccines in the past had a 72% to 75% effectiveness rate against mpox. Routine smallpox vaccinations were once common in the U.S. but ceased in 1972 after smallpox eradication. Those with prior smallpox vaccinations may still have some level of immunity against mpox.
Impacts of Mpox and Preventive Measures
Despite the efforts to contain the virus, mpox has caused significant fatalities worldwide, with several countries reporting outbreaks and deaths. It’s crucial to isolate individuals with mpox until their symptoms subside to prevent further transmission. While mpox has been declared a Public Health Emergency of International Concern (PHEIC) by the WHO, it has not yet been classified as a pandemic.
For individuals at risk of exposure to mpox, health care professionals may recommend vaccination. However, the CDC currently does not recommend universal vaccination against mpox. Proper hygiene practices, cleaning contaminated surfaces, and following preventive measures can help reduce the spread of the virus.
Stay Informed with VERIFY
As the situation with mpox evolves, it’s essential to stay informed and separate fact from fiction. The VERIFY team is dedicated to providing accurate information to help you navigate this challenging time. Consider subscribing to our newsletter, text alerts, and following us on social media platforms for the latest updates on mpox and other important topics.
